These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9683827)

  • 1. New multi-disciplinary treatment modality with RALS for patients with esophageal cancer.
    Toki T; Ogoshi S; Ogawa Y; Ohmori Y; Iwasa Y; Iwasa M; Nishioka A
    Oncol Rep; 1998; 5(5):1157-62. PubMed ID: 9683827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management for patients with advanced T4 epidermoid carcinoma of the esophagus.
    Wang LS; Chi KH; Hu MH; Fahn HJ; Huang MH
    J Surg Oncol; 1996 May; 62(1):22-9. PubMed ID: 8618396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus.
    Hennequin C; Gayet B; Sauvanet A; Blazy A; Perniceni T; Panis Y; Mal F; Sarfati E; Valleur P; Belghiti J; Fekete F; Maylin C
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):657-64. PubMed ID: 11172946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
    Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
    Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R
    Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of multidisciplinary treatment with high dose rate intraluminal brachytherapy on survival in patients with unresectable esophageal cancer.
    Iwasa M; Ohmori Y; Iwasa Y; Yamamoto A; Inoue A; Maeda H; Kume M; Ogoshi S; Nishioka A; Ogawa Y; Yoshida S
    Dig Surg; 1998; 15(3):227-35. PubMed ID: 9845590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
    Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
    Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancer.
    Knox JJ; Wong R; Visbal AL; Horgan AM; Guindi M; Hornby J; Xu W; Ringash J; Keshavjee S; Chen E; Haider M; Darling G
    Cancer; 2010 Sep; 116(17):4023-32. PubMed ID: 20533506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase II clinical trial of concurrent chemoradiotherapy (cisplatin plus 5-fluorouracil) for esophageal cancer].
    Lin Q; Gao XS; Qiao XY; Chen K; Wang YD; Zhou ZG
    Ai Zheng; 2008 Oct; 27(10):1077-81. PubMed ID: 18851788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
    Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [External irradiation combined with intracavitary brachytherapy for esophageal cancer].
    Zhou G; Chen G; Cui S; Sun J; Yang D
    Zhonghua Wai Ke Za Zhi; 2001 Dec; 39(12):925-7. PubMed ID: 16201172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
    Kim WC; Kim GE; Suh CO; Loh JJ
    Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207).
    Gaspar LE; Winter K; Kocha WI; Pinover WH; Herskovic ; Graham M; Gunderson L
    Cancer J; 2001; 7(5):388-94. PubMed ID: 11693897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of locally advanced esophageal cancer effectively treated with concurrent chemotherapy and radiotherapy].
    Segawa Y; Ohnoshi T; Ueoka H; Kiura K; Horiguchi T; Kodani T; Kamei H; Tabata M; Shibayama T; Maeda T
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):529-32. PubMed ID: 1373050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
    Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H
    Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of advanced esophageal cancer with extensive lymph node metastases successfully treated with multimodal therapy.
    Shigemitsu K; Naomoto Y; Shirakawa Y; Haisa M; Gunduz M; Tanaka N
    Jpn J Clin Oncol; 2002 Aug; 32(8):310-4. PubMed ID: 12411570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.